Cara Therapeutics Depreciation & Amortization 2011-2026 | CARA

Annual Depreciation & Amortization Cara Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
95 K	95 K	259 K	248 K	248 K	209 K	198 K	370 K	495 K	1.46 M	839 K	783 K	789 K	1.02 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.46 M	95 K	508 K

Quarterly Depreciation & Amortization Cara Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	42 K	-	-	-	58 K	-	187 K	126 K	63 K	-	186 K	124 K	63 K	-	147 K	96 K	48 K	-	150 K	100 K	50 K	-	318 K	239 K	125 K	-	370 K	245 K	122 K	-	1.35 M	1.25 M	730 K	-	580 K	386 K	193 K	-	590 K	393 K	197 K	-	592 K	395 K	198 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.35 M	42 K	303 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	920 K	$ 22.56	2.13 %	$ 3.74 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Akebia Therapeutics AKBA	1.27 M	$ 1.43	3.62 %	$ 368 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 327.25	2.42 %	$ 42.9 B	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.49	9.56 %	$ 397 M	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 20.4	-0.87 %	$ 954 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.18	1.21 %	$ 447 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.66	3.5 %	$ 16.7 M	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.61	5.76 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Cabaletta Bio CABA	1.65 M	$ 3.09	0.65 %	$ 310 M	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Codiak BioSciences CDAK	5.34 M	-	-55.98 %	$ 2.15 M	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Celldex Therapeutics CLDX	3.38 M	$ 32.41	3.38 %	$ 2.15 B	USA
Celsion Corporation CLSN	292 K	-	-6.63 %	$ 13.9 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Chimerix CMRX	91 K	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	1.48 M	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.88	2.11 %	$ 261 B	Britain